• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
THE DRUG-FASTNESS OF SPIROCHETES TO ARSENIC, MERCURIAL, AND IODIDE COMPOUNDS IN VITRO.体外实验中螺旋体对砷、汞和碘化合物的耐药性。
J Exp Med. 1917 Mar 1;25(3):349-62. doi: 10.1084/jem.25.3.349.
2
IMMUNOLOGICAL STUDIES ON PURE CULTURES OF VARIOUS SPIROCHETES.各种螺旋体纯培养的免疫学研究。
J Exp Med. 1917 Jun 1;25(6):765-88. doi: 10.1084/jem.25.6.765.
3
THE INFLUENCE OF CARBOHYDRATES ON THE CULTIVATION OF SPIROCHETES.碳水化合物对螺旋体培养的影响。
J Exp Med. 1917 Mar 1;25(3):375-80. doi: 10.1084/jem.25.3.375.
4
THE RESISTANCE OF SPIROCHETES TO THE ACTION OF HEXAMETHYLENETETRAMINE DERIVATIVES AND MERCURIAL AND ARSENIC COMPOUNDS.螺旋体对六亚甲基四胺衍生物以及汞和砷化合物的抗药性。
J Exp Med. 1917 Mar 1;25(3):363-73. doi: 10.1084/jem.25.3.363.
5
ETIOLOGY OF YELLOW FEVER : XII. CHEMOTHERAPY VERSUS SEROTHERAPY IN EXPERIMENTAL INFECTION WITH LEPTOSPIRA ICTEROIDES.黄热病的病因:十二. 钩端螺旋体黄疸型在实验感染中的化学疗法与血清疗法。
J Exp Med. 1920 Sep 30;32(4):381-400. doi: 10.1084/jem.32.4.381.
6
LEUCOCYTIC SECRETIONS.白细胞分泌产物。
J Exp Med. 1922 Nov 30;36(6):645-59. doi: 10.1084/jem.36.6.645.
7
CULTIVATION OF TREPONEMA CALLIGYRUM (NEW SPECIES) FROM CONDYLOMATA OF MAN.从人的湿疣中培养苍白密螺旋体(新种)。
J Exp Med. 1913 Jan 1;17(1):89-98. doi: 10.1084/jem.17.1.89.
8
PURE CULTIVATION OF SPIROCHAETA REFRINGENS.旋绕体的纯培养。
J Exp Med. 1912 May 1;15(5):466-9. doi: 10.1084/jem.15.5.466.
9
Nutritional requirements of anaerobic spirochetes. I. Demonstration of isobutyrate and bicarbonate as growth factors for a strain of Treponema microdentium.厌氧螺旋体的营养需求。I. 证明异丁酸和碳酸氢盐是微小密螺旋体菌株的生长因子。
J Bacteriol. 1966 Jan;91(1):27-32. doi: 10.1128/jb.91.1.27-32.1966.
10
A successful method for quantifying viable oral anaerobic spirochetes.一种定量活的口腔厌氧螺旋体的成功方法。
Oral Microbiol Immunol. 1993 Apr;8(2):80-3. doi: 10.1111/j.1399-302x.1993.tb00549.x.

引用本文的文献

1
Arsenic disturbs the gut microbiome of individuals in a disadvantaged community in Nepal.砷扰乱了尼泊尔一个贫困社区居民的肠道微生物群。
Heliyon. 2020 Jan 31;6(1):e03313. doi: 10.1016/j.heliyon.2020.e03313. eCollection 2020 Jan.
2
The Human Gut Microbiome's Influence on Arsenic Toxicity.人类肠道微生物群对砷毒性的影响。
Curr Pharmacol Rep. 2019 Dec;5(6):491-504. doi: 10.1007/s40495-019-00206-4. Epub 2019 Nov 25.
3
The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize.保罗·埃尔利希对药理学的贡献:在其诺贝尔奖获奖一百周年之际的致敬。
Pharmacology. 2008;82(3):171-9. doi: 10.1159/000149583. Epub 2008 Aug 5.
4
[Studies on Treponema for the cause of resistance to penicillin and terramycin in vitro].[关于梅毒螺旋体对青霉素和土霉素体外耐药原因的研究]
Arch Klin Exp Dermatol. 1960;210:400-8.
5
[The behavior of oral Treponema toward various factors of unspecific immunity].[口腔密螺旋体对非特异性免疫各种因素的反应]
Z Hyg Infektionskr. 1956;143(1):23-42.
6
[Culture of oral Treponema].[口腔密螺旋体培养]
Z Hyg Infektionskr. 1956;143(1):1-22.

体外实验中螺旋体对砷、汞和碘化合物的耐药性。

THE DRUG-FASTNESS OF SPIROCHETES TO ARSENIC, MERCURIAL, AND IODIDE COMPOUNDS IN VITRO.

机构信息

Laboratories of The Rockefeller Institute for Medical Research.

出版信息

J Exp Med. 1917 Mar 1;25(3):349-62. doi: 10.1084/jem.25.3.349.

DOI:10.1084/jem.25.3.349
PMID:19868093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2125488/
Abstract

In the foregoing experiments we attempted to determine whether or not, by subjecting several varieties of spirochetes to increasing doses of certain chemotherapeutic agents, a gradual increase of resistance to the latter could be shown. For this purpose, pure cultures of Treponema pallidum, Treponema microdentium, and Spirochoeta refringens were used against the action of salvarsan, neosalvarsan, bichloride of mercury, and iodine-iodide potassium solution in vitro. For culture media, the usual ascites-broth-tissue medium as well as solid ascites-agar-tissue medium was used. After permitting the spirochetes to grow for a fortnight in media containing certain quantities of each drug, transfers were made from tubes showing various degrees of growth to the next series of tubes containing the same drug in still higher concentrations, and similar transfers repeated every 2 weeks. The results of the experiments may be briefly summarized as follows: 1. Treponema pallidum and Treponema microdentium have, within 3 to 4 months, increased their tolerance to salvarsan and neosalvarsan to five and one-half times their original mark. With Spirochata refringens the increase was about three times. 2. Against the action of bichloride of mercury, the amount of increased tolerance of Treponema pallidum was about 35 to 70 times the original, while that of Treponema microdentium was about 10 times as much and was reached within 10 weeks. Spirochata refringens resisted 30 times the original dose. 3. There was an unmistakable increase of resistance of these spirochetes to the action of the iodine-iodide solution (Lugol's solution) when they were grown for several generations in fluid media containing the iodine solution, but the rate of increase between the initial and the acquired tolerance was slight. In general, the addition of Lugol"s solution to fluid media has a weak inhibitory influence upon the growth of the spirochetes, requiring for the total suppression of growth a quantity of over 0.7 cc. to 5 cc. of the culture media. The tolerance reached was for about three times that amount. 4. A similar tolerance phenomenon has not been established when employing a solid instead of a fluid medium containing the drugs. No explanation is offered except a suggestion that the drugs held in the agar do not enter into combination with certain tissue constituents of the medium as they are able to do with tissue elements in fluid media. This may be a factor necessary for inducing drug tolerance in these organisms in vitro. 5. The increased drug-fastness in vitro has a limit beyond which no further advance can be made. This limit varies with different species of spirochetes. 6. The acquired drug-fastness in vitro gradually disappears when the spirochetes are cultivated again in the drug-free media for several generations.

摘要

在上述实验中,我们试图确定通过对几种螺旋体菌株进行递增剂量的某些化学治疗药物处理,是否可以显示出后者的耐药性逐渐增加。为此,我们使用苍白密螺旋体、微小密螺旋体和放射形密螺旋体的纯培养物,在体外对抗胂凡纳明、新胂凡纳明、二氯化汞和碘碘化钾溶液的作用。对于培养基,我们使用了通常的腹水-肉汤-组织培养基以及固体腹水-琼脂-组织培养基。在含有一定量每种药物的培养基中让螺旋体生长两周后,将显示出不同生长程度的试管转移到下一系列含有相同药物但浓度更高的试管中,并且每两周重复类似的转移。实验结果可以简要概括如下:

  1. 苍白密螺旋体和微小密螺旋体在 3 到 4 个月内将对胂凡纳明和新胂凡纳明的耐受性增加了五倍半至原来的标记。放射形密螺旋体的增加约为三倍。

  2. 对抗二氯化汞的作用,苍白密螺旋体的耐受力增加了约 35 至 70 倍,而微小密螺旋体的耐受力增加了约 10 倍,在 10 周内达到。放射形密螺旋体抵抗原来剂量的 30 倍。

  3. 当这些螺旋体在含有碘溶液的液体培养基中生长几代时,它们对碘-碘化钾溶液(卢戈氏液)的作用的耐药性有明显增加,但初始和获得的耐药性之间的增加率很小。一般来说,向液体培养基中添加卢戈氏液对螺旋体的生长有较弱的抑制作用,需要超过 0.7 毫升至 5 毫升的培养基才能完全抑制生长。达到的耐受力约为三倍。

  4. 当使用含有药物的固体而不是液体培养基时,没有建立类似的耐受力现象。除了建议药物在琼脂中保持不与培养基中的某些组织成分结合之外,没有提供任何解释,因为它们能够与液体培养基中的组织元素结合。这可能是在体外诱导这些生物体产生药物耐药性的必要因素。

  5. 体外药物耐药性有一个极限,超过这个极限就无法再进一步提高。这个极限因不同的螺旋体物种而异。

  6. 当螺旋体再次在无药物的培养基中培养几代时,体外获得的药物耐药性逐渐消失。